false 0000948320 0000948320 2024-12-18 2024-12-18 0000948320 LFMD:CommonStockParValue0.01PerShareMember 2024-12-18 2024-12-18 0000948320 LFMD:SeriesCumulativePerpetualPreferredStock0.0001PerShareMember 2024-12-18 2024-12-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 18, 2024

 

LIFEMD, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware   001-39785   76-0238453

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

236 Fifth Avenue, Suite 400

New York, NY 10001

(Address of principal executive offices, including zip code)

 

(866) 351-5907

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   LFMD   The Nasdaq Capital Market
Series A Cumulative Perpetual Preferred Stock, $0.0001 per share   LFMDP   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Director Resignation

 

On December 18, 2024, Robert Jindal voluntarily resigned from his position as a member of the board of directors (the “Board”) of LifeMD, Inc. (the “Company”), effective December 31, 2024. Mr. Jindal did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. The Company thanks Mr. Jindal for his service on the Board and many other contributions to the Company.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    LIFEMD, INC.
       
Dated: December 23, 2024 By: /s/ Eric H. Yecies
      Eric H. Yecies
      Chief Legal Officer and General Counsel

 

 

 

v3.24.4
Cover
Dec. 18, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 18, 2024
Entity File Number 001-39785
Entity Registrant Name LIFEMD, INC.
Entity Central Index Key 0000948320
Entity Tax Identification Number 76-0238453
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 236 Fifth Avenue
Entity Address, Address Line Two Suite 400
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10001
City Area Code (866)
Local Phone Number 351-5907
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, par value $0.01 per share  
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol LFMD
Security Exchange Name NASDAQ
Series A Cumulative Perpetual Preferred Stock, $0.0001 per share  
Title of 12(b) Security Series A Cumulative Perpetual Preferred Stock, $0.0001 per share
Trading Symbol LFMDP
Security Exchange Name NASDAQ
LifeMD (NASDAQ:LFMDP)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 LifeMD 차트를 더 보려면 여기를 클릭.
LifeMD (NASDAQ:LFMDP)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 LifeMD 차트를 더 보려면 여기를 클릭.